Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 101–200 of 1,001
Hovorka, R., Kumareswaran, K., Harris, J., Allen, J. M., Elleri, D., Xing, D., Kollman, C., Nodale, M., Murphy, H. R., Dunger, D. B., et al. (2011) · BMJ · doi:10.1136/bmj.d1855 · Cited by 244
Cengiz, E., Xing, D., Wong, J. C., Wolfsdorf, J. I., Haymond, M. W., Rewers, A., Shanmugham, S., Tamborlane, W. V., Willi, S. M., Seiple, D. L., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12030 · Cited by 243
Šoupal, J., Petruželková, L., Grunberger, G., Hásková, A., Flekač, M., Matoulek, M., Mikeš, O., Pelcl, T., Škrha, J., Horová, E., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0888 · Cited by 242
Advances in technology for management of type 1 diabetes
Beck, R. W., Bergenstal, R. M., Laffel, L. M., & Pickup, J. C. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31142-0 · Cited by 242
Nimri, R., Battelino, T., Laffel, L. M., Slover, R. H., Schatz, D., Weinzimer, S. A., Dovc, K., Danne, T., Phillip, M., NextDREAM Consortium, et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1045-7 · Cited by 242
Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment
Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2017) · Electronics · doi:10.3390/electronics6030065 · Cited by 237
Raccah, D., Sulmont, V., Reznik, Y., Guerci, B., Renard, E., Hanaire, H., Jeandidier, N., & Nicolino, M. (2009) · Diabetes Care · doi:10.2337/dc09-0750 · Cited by 237
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234
DeSalvo, D. J., Miller, K. M., Hermann, J. M., Maahs, D. M., Hofer, S. E., Clements, M. A., Lilienthal, E., Sherr, J. L., Tauschmann, M., Holl, R. W., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12711 · Cited by 233
Abraham, M. B., Jones, T. W., Naranjo, D., Karges, B., Oduwole, A., Tauschmann, M., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12698 · Cited by 226
“severe hypoglycemia with the use of CGM in children and young adults.(170)”
In situ monitoring of health in older adults: technologies and issues
Kang, H. G., Mahoney, D. F., Hoenig, H., Hirth, V. A., Bonato, P., Hajjar, I., Lipsitz, L. A., & for the Center for Integration of Medicine and Innovative Technology Working Group on Advanced Approaches to Physiologic Monitoring for the Aged (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02959.x · Cited by 227
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 215
Hovorka, R., Elleri, D., Thabit, H., Allen, J. M., Leelarathna, L., El-Khairi, R., Kumareswaran, K., Caldwell, K., Calhoun, P., Kollman, C., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2644 · Cited by 214
The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2013) · Diabetes Care · doi:10.2337/dc12-2360 · Cited by 214
Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline
Klonoff, D. C., Buckingham, B., Christiansen, J. S., Montori, V. M., Tamborlane, W. V., Vigersky, R. A., & Wolpert, H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2756 · Cited by 211
O’Connell, M. A., Donath, S., O’Neal, D. N., Colman, P. G., Ambler, G. R., Jones, T. W., Davis, E. A., & Cameron, F. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1365-0 · Cited by 211
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s009 · Cited by 205
Hypoglycemia in Type 1 Diabetes Mellitus
Cryer, P. E. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.003 · Cited by 205
Mauras, N., Beck, R., Xing, D., Ruedy, K., Buckingham, B., Tansey, M., White, N. H., Weinzimer, S. A., Tamborlane, W., Kollman, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1746 · Cited by 204
Self-citation7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
Cerebral ischemic damage in diabetes: an inflammatory perspective
Shukla, V., Shakya, A. K., Perez-Pinzon, M. A., & Dave, K. R. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0774-5 · Cited by 200
Kovatchev, B., Cobelli, C., Renard, E., Anderson, S., Breton, M., Patek, S., Clarke, W., Bruttomesso, D., Maran, A., Costa, S., et al. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400611 · Cited by 200
Ehrhardt, N. M., Chellappa, M., Walker, M. S., Fonda, S. J., & Vigersky, R. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500320 · Cited by 199
ISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies
Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12731 · Cited by 197
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus
Lin, R., Brown, F., James, S., Jones, J., & Ekinci, E. (2021) · Diabetic Medicine · doi:10.1111/dme.14528 · Cited by 197
Shah, V. N., Laffel, L. M., Wadwa, R. P., & Garg, S. K. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0143 · Cited by 197
Charleer, S., Mathieu, C., Nobels, F., De Block, C., Radermecker, R. P., Hermans, M. P., Taes, Y., Vercammen, C., T'Sjoen, G., Crenier, L., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02498 · Cited by 196
Fonseca, V. A., Grunberger, G., Anhalt, H., Bailey, T. S., Blevins, T., Garg, S. K., Handelsman, Y., Hirsch, I. B., Orzeck, E. A., Roberts, V. L., et al. (2016) · Endocrine Practice · doi:10.4158/ep161392.cs · Cited by 195
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 288
Effectiveness of a Regional Prepregnancy Care Program in Women With Type 1 and Type 2 Diabetes
Murphy, H. R., Roland, J. M., Skinner, T. C., Simmons, D., Gurnell, E., Morrish, N. J., Soo, S.-C., Kelly, S., Lim, B., Randall, J., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1113 · Cited by 186
Evans, M., Welsh, Z., Ells, S., & Seibold, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00720-0 · Cited by 185
Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications
Hirsch, I. B. (2010) · JAMA · doi:10.1001/jama.2010.785 · Cited by 184
Challenges and recent progress in the development of a closed-loop artificial pancreas
Bequette, B. W. (2012) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2012.09.007 · Cited by 183
Grunberger, G., Abelseth, J. M., Bailey, T. S., Bode, B. W., Handelsman, Y., Hellman, R., Jovanovič, L., Lane, W. S., Raskin, P., Tamborlane, W. V., et al. (2014) · Endocrine Practice · doi:10.4158/ep14145.ps · Cited by 180
Zecchin, C., Facchinetti, A., Sparacino, G., De Nicolao, G., & Cobelli, C. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2012.2188893 · Cited by 178
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-2081 · Cited by 180
Function of an Implanted Tissue Glucose Sensor for More than 1 Year in Animals
Gough, D. A., Kumosa, L. S., Routh, T. L., Lin, J. T., & Lucisano, J. Y. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001148 · Cited by 179
7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s007 · Cited by 179
Poolsup, N., Suksomboon, N., & Kyaw, A. M. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-39 · Cited by 179
Design, Development, and Evaluation of a Novel Microneedle Array-based Continuous Glucose Monitor
Jina, A., Tierney, M. J., Tamada, J. A., McGill, S., Desai, S., Chua, B., Chang, A., & Christiansen, M. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814526191 · Cited by 176
Continuous glucose monitoring sensors: past, present and future algorithmic challenges
Facchinetti, A. (2016) · Sensors · doi:10.3390/s16122093 · Cited by 176
Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors
Vettoretti, M., Cappon, G., Facchinetti, A., & Sparacino, G. (2020) · Sensors · doi:10.3390/s20143870 · Cited by 176
“The use of rtCGM sensors has proved to be very beneficial for glycemic control [10,16,17].”
MethodInsulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
Choudhary, P., Shin, J., Wang, Y., Evans, M. L., Hammond, P. J., Kerr, D., Shaw, J. A. M., Pickup, J. C., & Amiel, S. A. (2011) · Diabetes Care · doi:10.2337/dc10-2411 · Cited by 175
Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention
Nakhleh, A., & Shehadeh, N. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i12.2036 · Cited by 154
Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Buckingham, B., Chase, H. P., Dassau, E., Cobry, E., Clinton, P., Gage, V., Caswell, K., Wilkinson, J., Cameron, F., Lee, H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2303 · Cited by 169
“The glucose level was ≤ 70 mg/dL on 25% of nights, ≤ 60 mg/dL on 15% of nights and ≤ 50 mg/dL on 8% of nights (unpublished data) (5).”
BackgroundMethodHermanides, J., Nørgaard, K., Bruttomesso, D., Mathieu, C., Frid, A., Dayan, C. M., Diem, P., Fermon, C., Wentholt, I. M. E., Hoekstra, J. B. L., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03256.x · Cited by 169
Nimri, R., Muller, I., Atlas, E., Miller, S., Fogel, A., Bratina, N., Kordonouri, O., Battelino, T., Danne, T., & Phillip, M. (2014) · Diabetes Care · doi:10.2337/dc14-0835 · Cited by 169
Tyndall, V., Stimson, R. H., Zammitt, N. N., Ritchie, S. A., McKnight, J. A., Dover, A. R., & Gibb, F. W. (2019) · Diabetologia · doi:10.1007/s00125-019-4894-1 · Cited by 165
Hypoglycemia, Diabetes, and Cardiovascular Disease
Snell-Bergeon, J. K., & Wadwa, R. P. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0031 · Cited by 161
“44 Acute hypoglycemia invokes a cascade of physiologic responses, including the activation of inflammatory pathways, release of counterregulatory hormones including epinephrine, and reduced blood flow to the myocardium.”
Leney, S. E., & Tavaré, J. M. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0037 · Cited by 161
Kanderian, S. S., Weinzimer, S., Voskanyan, G., & Steil, G. M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300508 · Cited by 161
Oskarsson, P., Antuna, R., Geelhoed-Duijvestijn, P., Krӧger, J., Weitgasser, R., & Bolinder, J. (2018) · Diabetologia · doi:10.1007/s00125-017-4527-5 · Cited by 160
Choudhary, P., Ramasamy, S., Green, L., Gallen, G., Pender, S., Brackenridge, A., Amiel, S. A., & Pickup, J. C. (2013) · Diabetes Care · doi:10.2337/dc13-0939 · Cited by 160
Technology in the management of type 1 diabetes mellitus — current status and future prospects
Tauschmann, M., & Hovorka, R. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0044-y · Cited by 183
for the DPV Initiative and the T1D Exchange Clinic Network, Maahs, D. M., Hermann, J. M., DuBose, S. N., Miller, K. M., Heidtmann, B., DiMeglio, L. A., Rami-Merhar, B., Beck, R. W., Schober, E., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3272-2 · Cited by 159
A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes
Maahs, D. M., Calhoun, P., Buckingham, B. A., Chase, H. P., Hramiak, I., Lum, J., Cameron, F., Bequette, B. W., Aye, T., Paul, T., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2159 · Cited by 160
Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes
Elleri, D., Allen, J. M., Kumareswaran, K., Leelarathna, L., Nodale, M., Caldwell, K., Cheng, P., Kollman, C., Haidar, A., Murphy, H. R., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0816 · Cited by 158
Hilliard, M. E., Powell, P. W., & Anderson, B. J. (2016) · American Psychologist · doi:10.1037/a0040359 · Cited by 157
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 206
An alternative sensor-based method for glucose monitoring in children and young people with diabetes
Edge, J., Acerini, C., Campbell, F., Hamilton-Shield, J., Moudiotis, C., Rahman, S., Randell, T., Smith, A., & Trevelyan, N. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-311530 · Cited by 156
Scott, E. M., Bilous, R. W., & Kautzky-Willer, A. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0386 · Cited by 153
Strambini, L. M., Longo, A., Scarano, S., Prescimone, T., Palchetti, I., Minunni, M., Giannessi, D., & Barillaro, G. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.11.010 · Cited by 154
“Subcutaneously-implanted systems working on ISF and allowing for continuous glucose monitoring up to one week have then come to market in the effort to alleviate discomfort by repeated injections (Tamborlane et al., 2008; Lodwig et al., 2014).”
BackgroundIn Vivo Dynamic Monitoring of Small Molecules with Implantable Polymer-Dot Transducer
Sun, K., Tang, Y., Li, Q., Yin, S., Qin, W., Yu, J., Chiu, D. T., Liu, Y., Yuan, Z., Zhang, X., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02386 · Cited by 149
Zhu, T., Li, K., Herrero, P., & Georgiou, P. (2023) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2022.3187703 · Cited by 135
The Chemistry of Commercial Continuous Glucose Monitors
McGarraugh, G. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0133 · Cited by 144
Insulin treatment in children and adolescents with diabetes
Bangstad, H., Danne, T., Deeb, L. C., Jarosz-Chobot, P. A., Urakami, T., & Hanås, R. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00578.x · Cited by 160
Kassahun, T., Eshetie, T., & Gesesew, H. (2016) · BMC Research Notes · doi:10.1186/s13104-016-1896-7 · Cited by 135
Improving the clinical value and utility of CGM systems: issues and recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetologia · doi:10.1007/s00125-017-4463-4 · Cited by 148
Chase, H. P., Beck, R. W., Xing, D., Tamborlane, W. V., Coffey, J., Fox, L. A., Ives, B., Keady, J., Kollman, C., Laffel, L., et al. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0021 · Cited by 139
Alkhalidy, H., Moore, W., Wang, Y., Luo, J., McMillan, R. P., Wei, Z., Zhou, K., & Liu, D. (2018) · Molecules · doi:10.3390/molecules23092338 · Cited by 151
“Continuous glucose monitoring and intensive treatment showed improvements in glycemic control of adult patients but weren’t efficient in younger patients who are more commonly diagnosed with this disease [21].”
BackgroundClosed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes
Murphy, H. R., Elleri, D., Allen, J. M., Harris, J., Simmons, D., Rayman, G., Temple, R., Dunger, D. B., Haidar, A., Nodale, M., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1796 · Cited by 137
Christiansen, M., Bailey, T., Watkins, E., Liljenquist, D., Price, D., Nakamura, K., Boock, R., & Peyser, T. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0077 · Cited by 136
Gandhi, G. Y., Kovalaske, M., Kudva, Y., Walsh, K., Elamin, M. B., Beers, M., Coyle, C., Goalen, M., Murad, M. S., Erwin, P. J., et al. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500419 · Cited by 134
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetes Care · doi:10.2337/dci17-0043 · Cited by 135
Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring
Sharma, S., Huang, Z., Rogers, M., Boutelle, M., & Cass, A. E. G. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9961-6 · Cited by 132
McCall, A. L., Lieb, D. C., Gianchandani, R., MacMaster, H., Maynard, G. A., Murad, M. H., Seaquist, E., Wolfsdorf, J. I., Wright, R. F., & Wiercioch, W. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac596 · Cited by 123
Use of Microneedle Array Devices for Continuous Glucose Monitoring: A Review
El-Laboudi, A., Oliver, N. S., Cass, A., & Johnston, D. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0188 · Cited by 131
Riveline, J.-P., Teynie, J., Belmouaz, S., Franc, S., Dardari, D., Bauwens, M., Caudwell, V., Ragot, S., Bridoux, F., Charpentier, G., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp181 · Cited by 133
Recent Advances in Wearable Sensing Technologies
Pérez, A. J., & Zeadally, S. (2021) · Sensors · doi:10.3390/s21206828 · Cited by 155
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring
Xing, D., Kollman, C., Beck, R. W., Tamborlane, W. V., Laffel, L., Buckingham, B. A., Wilson, D. M., Weinzimer, S., Fiallo-Scharer, R., & Ruedy for the Juvenile Diabetes Research Foundation Continuo, K. J. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0156 · Cited by 131
Leelarathna, L., Dellweg, S., Mader, J. K., Allen, J. M., Benesch, C., Doll, W., Ellmerer, M., Hartnell, S., Heinemann, L., Kojzar, H., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2911 · Cited by 130
Insulin treatment in children and adolescents with diabetes
Danne, T., Bangstad, H.-J., Deeb, L., Jarosz-Chobot, P., Mungaie, L., Saboo, B., Urakami, T., Battelino, T., & Hanas, R. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12184 · Cited by 131
Barnard, K. D., Wysocki, T., Ully, V., Mader, J. K., Pieber, T. R., Thabit, H., Tauschmann, M., Leelarathna, L., Hartnell, S., Acerini, C. L., et al. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817702656 · Cited by 126
Modeling the glucose sensor error
Facchinetti, A., Del Favero, S., Sparacino, G., Castle, J. R., Ward, W. K., & Cobelli, C. (2014) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2284023 · Cited by 130
Rodbard, D., Bailey, T., Jovanovic, L., Zisser, H., Kaplan, R., & Garg, S. K. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0077 · Cited by 131
Liraglutide as additional treatment for type 1 diabetes
Varanasi, A., Bellini, N., Rawal, D., Vora, M., Makdissi, A., Dhindsa, S., Chaudhuri, A., & Dandona, P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0330 · Cited by 129
Kowalski, A. J. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0031 · Cited by 127
Šoupal, J., Petruželková, L., Flekač, M., Pelcl, T., Matoulek, M., Daňková, M., Škrha, J., Svačina, Š., & Prázný, M. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0171 · Cited by 126
Bailey, T. S., Grunberger, G., Bode, B. W., Handelsman, Y., Hirsch, I. B., Jovanovič, L., Roberts, V. L., Rodbard, D., Tamborlane, W. V., & Walsh, J. S. A. (2016) · Endocrine Practice · doi:10.4158/ep151124.cs · Cited by 149
Messer, L. H., Forlenza, G. P., Sherr, J. L., Wadwa, R. P., Buckingham, B. A., Weinzimer, S. A., Maahs, D. M., & Slover, R. H. (2018) · Diabetes Care · doi:10.2337/dc17-1682 · Cited by 126
Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners
Ajjan, R., Slattery, D., & Wright, E. (2019) · Advances in Therapy · doi:10.1007/s12325-019-0870-x · Cited by 120
Helton, K. L., Ratner, B. D., & Wisniewski, N. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500317 · Cited by 125
Sherr, J. L., Cengiz, E., Palerm, C. C., Clark, B., Kurtz, N., Roy, A., Carria, L., Cantwell, M., Tamborlane, W. V., & Weinzimer, S. A. (2013) · Diabetes Care · doi:10.2337/dc13-0010 · Cited by 125
Kordonouri, O., Pańkowska, E., Rami-Merhar, B. M., Kapellen, T. M., Coutant, R., Hartmann, R., Lange, K., Knip, M., & Danne, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1878-6 · Cited by 133
Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes
Tansey, M., Laffel, L., Cheng, J., Beck, R., Coffey, J., Huang, E., Kollman, C., Lawrence, J., Lee, J., Ruedy, K., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03368.x · Cited by 125
A pilot study in humans of microneedle sensor arrays for continuous glucose monitoring
Sharma, S., El-Laboudi, A., Reddy, M., Jugnee, N., Sivasubramaniyam, S., El Sharkawy, M., Georgiou, P., Johnston, D., Oliver, N., & Cass, A. E. G. (2018) · Analytical Methods · doi:10.1039/c8ay00264a · Cited by 123
Current Advances in the Management of Diabetes Mellitus
Aloke, C., Egwu, C. O., Aja, P. M., Obasi, N. A., Chukwu, J. A., Akumadu, B. O., Ogbu, P. N., & Achilonu, I. (2022) · Biomedicines · doi:10.3390/biomedicines10102436 · Cited by 157
Leelarathna, L., English, S. W., Thabit, H., Caldwell, K., Allen, J. M., Kumareswaran, K., Wilinska, M. E., Nodale, M., Mangat, J., Evans, M. L., et al. (2013) · Critical Care · doi:10.1186/cc12838 · Cited by 120
Lucisano, J. Y., Routh, T. L., Lin, J. T., & Gough, D. A. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2619333 · Cited by 136
Polonsky, W. H., & Hessler, D. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0298 · Cited by 116
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.